2010
DOI: 10.1136/gut.2009.200105
|View full text |Cite
|
Sign up to set email alerts
|

PRSS3 promotes tumour growth and metastasis of human pancreatic cancer

Abstract: PRSS3 plays an important role in the progression, metastasis and prognosis of human pancreatic cancer. Targeting the PRSS3 signalling pathway may be an effective and feasible approach for treatment of this lethal cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
97
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 73 publications
(104 citation statements)
references
References 34 publications
5
97
0
Order By: Relevance
“…10 All primary antisera were purchased from Santa Cruz Biotechnology (Paso Robles, CA, USA). After being blocked for 1 h at 37°C in phosphate buffered saline (PBS) containing 5% goat serum and 0.3% Triton X-100, the sections were incubated with primary antibodies GFAP and vimentin, or primary antibodies p-p38MAPK and p-JNK overnight at 4°C, respectively.…”
Section: Immunohistochemistrymentioning
confidence: 99%
“…10 All primary antisera were purchased from Santa Cruz Biotechnology (Paso Robles, CA, USA). After being blocked for 1 h at 37°C in phosphate buffered saline (PBS) containing 5% goat serum and 0.3% Triton X-100, the sections were incubated with primary antibodies GFAP and vimentin, or primary antibodies p-p38MAPK and p-JNK overnight at 4°C, respectively.…”
Section: Immunohistochemistrymentioning
confidence: 99%
“…This difference may be due to the ability of cathepsin-L to degrade extracellular matrix allowing for more tumor growth in those tumors expressing high levels of cathepsin-L. Mesotrypsinogen (PRSS3) has been found to be overexpressed in pancreatic cancer cell lines and promotes cell proliferation and invasion in cell culture, while in vivo it causes both tumor growth and metastasis. This data suggests that modulation of the PRSS3 signaling pathway may be a viable approach for treating pancreatic cancer (Jiang et al, 2010).…”
Section: Role Of Premature Trypsinogen Activationmentioning
confidence: 99%
“…These alternative isoforms, trypsinogens 4 and 5, do not possess classic signal sequences, and the mechanisms by which they are trafficked and activated are not yet fully elucidated, but functional studies provide evidence for significant roles for active mesotrypsin in keratinocyte differentiation and skin desquamation (6,7). PRSS3 transcripts, primarily encoding trypsinogen 4, are also expressed in many epithelial cells and cancers, and functional studies likewise provide evidence for extracellular roles for active mesotrypsin in tumor progression of breast (8), pancreatic (9), and prostate cancers (10,11). An unusual feature of mesotrypsin is its extreme resistance to endogenous proteinaceous trypsin inhibitors (1,12,13) and its ability to digest some of these inhibitors as substrates (6,14,15).…”
Section: Mesotrypsin Is An Isoform Of Trypsin That Is Uniquely Resistmentioning
confidence: 99%